10 years ago, a psychiatrist stood before Kaiser Permanente's committee with an unconventional proposal: bringing ketamine therapy to one of America's largest health systems.
"You have to understand how incredible this was," recalls Dr. L. Alison McInnes MD, MS,VP of Scientific Affairs at Osmind.
"You have to understand how incredible this was," recalls Dr. L. Alison McInnes MD, MS,VP of Scientific Affairs at Osmind.
Comments
From that pioneering hospital program to today's clinics across the country, McInnes shares what a decade on the frontlines has taught us:
-What 7,000+ real patient outcomes reveal about treatment possibilities
-The unexpected role of psychotherapy in ketamine's success
-Why access remains the field's biggest challenge - and how we're solving it
https://www.osmind.org/blog/the-ketamine-breakthrough-10-year